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Introduction: Infectious disease in an immunosuppressed patient is a diagnostic challenge. The clinical
presentation and the body’s immune response may be quite different from those seen in an immunocompetent
patient with the same infection. It is also a race against time to diagnose, as many of these infections can be fatal
without timely intervention.
Case presentation: We present the case of a 39-year-old Sri Lankan woman who was on immunosuppressive
treatment for systemic lupus erythematosis and who presented with multiple ring-enhancing lesions of the brain.
The most likely diagnosis, given the clinical picture, available investigation results, and characteristics of magnetic
resonance imaging, was central nervous system tuberculosis. Owing to the small size of the lesions, a tissue biopsy
could not be performed. Our patient responded well to a trial of anti-tuberculosis therapy, and there was clinical
and radiological evidence of recovery. A paradoxical reaction with the initiation of anti-tuberculosis therapy was
observed and this had to be countered with a prolonged course of steroids.
Conclusions: Our experience and previous evidence from case reports suggest that high-dose steroids for a
prolonged period (up to eight weeks) should be administered to counter the initial deterioration after starting
anti-tuberculous chemotherapy for central nervous system tuberculomas.Introduction
Infectious disease in an immunosuppressed patient pre-
sents many challenges. First, the characteristic features of
infection seen in an immunocompetent person are ab-
sent; instead, there will be a spectrum of unfamiliar and
rare manifestations. Second, many atypical organisms
that are non-virulent in immunocomptent individuals
can cause severe disease. Third, owing to malfunction of
the host immune system, diagnostic tests may fail to pro-
duce positive results. Fourth, rapid pathogen multiplica-
tion and dissemination would afford limited time for
diagnosis and treatment to save the life of the patient [1].
To highlight some of these challenges, we report the case
of a patient who was on immunosuppressive therapy for
systemic lupus erythematosis (SLE) and who developed
multiple ring-enhancing lesions throughout the brain.* Correspondence: chaturaka.rodrigo@gmail.com
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A 39-year-old Sri Lankan woman presented with a
two-week history of nausea, vomiting, severe headache,
progressive drowsiness associated with high-grade inter-
mittent fever, and confusion. SLE had been diagnosed
five years before. At that time, she had had signs and
symptoms of arthralgia, malar rash, alopecia, and anti-
nuclear antibody and anti-double-stranded deoxyribo-
nucleic acid antibody positivity on serum. Hypertension
was diagnosed at the same time and was later treated as
essential hypertension. The initial presentation of SLE
was treated with high-dose prednisolone and mycophe-
nolate mofetil (MMF). The prednisolone dose had been
tapered off over the years, but MMF had been continued
at high doses (1 g/day). Our patient had been poorly
compliant to follow-up and had self-medicated at times
with repeat prescriptions of steroids. Although the SLE
activity was in remission, she was on inappropriately high
doses of immunosuppressants (the indication to start
MMF was unclear in the records). Apart from hyperten-
sion, her medical history was unremarkable, and she was
not on any other immunosuppressants. No relevant sexualLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A magnetic resonance image with gadolinium
enhancement at initial presentation. The image shows multiple
ring-enhancing lesions spread diffusely throughout the brain.
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was reported.
On admission, she was drowsy, febrile, and confused.
Her Glasgow Coma Scale score was 12 out of 15. She
had no neck stiffness. The results of a cranial nerve
examination, including funduscopy, were normal. Bilat-
eral exaggerated tendon reflexes in her limbs and bilat-
eral extensor plantar responses were noted during a
neurological examination. She had no lymphadenopathy
or peripheral manifestations of active SLE. Her cardio-
vascular system was normal apart from a blood pressure
of 150/90 mmHg. She had a non-tender, firm hepato-
megaly extending 3 cm below her costal margin. The
results of the rest of the abdominal examination and the
respiratory system were normal. Her hemoglobin level
was 9.8 mg/dL, her total leukocyte count was 21.5×109/L
with 88% neutrophils, her platelet count was 324×109/L,
and her blood picture showed a normochromic nor-
mocytic anemia with a left shift of leukocytes. Her
erythrocyte sedimentation rate was 90 mm/hour, and her
C-reactive protein was 46 mg/L (the reference value was
less than 6), but her serum complement levels were
within normal limits. Her blood and urine cultures were
sterile, and her chest X-ray was normal. Transthoracic
and transesophageal echocardiograms were normal. An
ultrasound scan of her abdomen did not show focal
lesions in her liver, which was enlarged, or any other foci
of sepsis. Her serum electrolytes, including calcium and
magnesium levels, blood glucose, and liver and renal
function tests, were also within normal limits.
Gadolinium-enhanced magnetic resonance imaging
(MRI) of her brain showed multiple ring-enhancing
lesions that were of varying sizes, up to 1 cm in diam-
eter, and that were surrounded by marked perilesional
edema involving her cortex, basal ganglia, brain stem,
and cerebellum (Figure 1). There was meningeal en-
hancement as well.
A cerebrospinal fluid (CSF) analysis showed lympho-
cytic pleocytosis, an elevated protein level of 108 mg/dL,
and a low CSF-to-serum glucose ratio of 1.8:5.8. There
were no atypical cells on CSF cytology, and bacterial,
fungal, and tuberculous cultures of CSF were negative.
The toxoplasma antibody titers were negative for im-
munoglobulin M but positive for immunoglobulin G
(1:150). The fungal cultures were sterile. The results of
the human immunodeficiency virus antibody test were
negative. The serum lactate dehydrogenase level was
normal. Our patient was initially treated with broad-
spectrum intravenous antibiotics with both aerobic and
anaerobic cover (meropenem and metronidazole) com-
bined with steroids – dexamethasone 4 mg three times a
day (t.i.d.) – to reduce perilesional edema. Owing to the
minute size of the lesions, a biopsy for histology was not
possible. However, given the poor response to antibioticsand given the likelihood of central nervous system
(CNS) tuberculosis (TB) as evidenced by the clinical
presentation and context, MRI characteristics, CSF
analysis, and elevated inflammatory markers, anti-
tuberculous chemotherapy (ATT) was empirically com-
menced and the steroids (dexamethasone 4 mg t.i.d.)
were continued. The treatment doses of ATT were iso-
niazid 300 mg daily, rifampicin 450 mg daily, ethambutol
800 mg daily, and pyrazinamide 1.5 g daily for the first
two months and then isoniazid and rifampicin were con-
tinued at the same doses for the rest of the duration.
Antibiotics were omitted. The high-grade intermittent
fever gradually subsided, but after one month of ATT,
our patient became increasingly drowsy with pressure
headaches and intractable vomiting, which corresponded
to an increase in the size of the brain lesions and perile-
sional edema seen on MRI (paradoxical reaction). The
dose of steroids was increased (dexamethasone 8 mg
t.i.d.), and ATT was continued. From the third month of
ATT, our patient showed steady improvement in clinical
status, including improvement of level of consciousness
with resolution of pressure headaches and intractable
vomiting, improved appetite, and independent ambula-
tion. A follow-up MRI at the end of the third month
showed a significant (approximately 60%) reduction in
the number of lesions (Figure 2). The dexamethasone
dose was reduced (by reducing both dose and frequency
and by titrating dose according to symptoms) and later
converted to prednisolone. Our patient was discharged
on ATT to be continued for 18 months. At discharge,
she was also on 20 mg of prednisolone and 75 mg of
Figure 2 Magnetic resonance image after three months of anti-
tuberculosis therapy. The image, which corresponds to that of
Figure 1, shows a marked reduction in the number of lesions.
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improved and was independent in most activities of daily
living without any remission of SLE. She was off steroids
by this time.
Discussion
The occurrence of multiple tuberculomas in the brain of
immunosuppressed patients has been reported previ-
ously, but reports of cerebral tuberculomas that are as
extensive as in our patient and that are associated with a
good outcome following ATT are rare [2,3]. As differen-
tial diagnoses for multiple ring-enhancing cerebral
lesions, the following were considered in our patient:
tuberculomas, pyogenic abscesses, toxoplasmosis, cysti-
cercosis, fungal infections, and neoplasms such as CNS
lymphomas or metastatic deposits.
The background immunosuppression, the insidious
onset, MRI characteristics, elevated inflammatory mar-
kers, and the lymphocytic pleocytosis in the CSF asso-
ciated with a high protein and low CSF-to-serum glucose
ratio favored TB as the most likely etiology. However,
there was no contact history of TB and the chest X-ray
was normal. The insidious onset and CSF characteristics
were not consistent with pyogenic abscesses, and the
results of screening investigations for fungal infections,
parasitic infections, and malignancy were negative.
Tuberculomas are conglomerate caseous foci within
the substance of the brain and develop from deep-
seated tubercles acquired during a recent or remote
hematogenous bacillemia. Tuberculomas can involve
the brain, spinal cord, and subarachnoid, subdural, orepidural space and may be solitary or multiple. In adults,
lesions are found predominantly in the supratentorial
compartment in the frontal and parietal lobes. The clin-
ical presentation of tuberculomas is often protean and
includes headache, focal neurological signs, seizures,
papilloedema, and fever. CSF analysis is usually non-
specific, and cultures are often negative. Polymerase
chain reaction for tubercle bacilli is insensitive [4].
Therefore, the diagnosis is usually based on neuroima-
ging characteristics and the clinical context. The radio-
logical presentation depends on whether the granuloma
is non-caseating, caseating with a solid center, or caseat-
ing with a liquid center. The non-caseating granuloma
on contrast-enhanced CT (CECT) is characteristically
round, oval, or lobular; varies from 1 to 50 mm; and
enhances homogenously. On MRI, these lesions are
hyperintense on T2-weighted acquisitions and homoge-
nously enhance with contrast. They are frequently sur-
rounded by a halo of contiguous vasogenic white matter
edema [5,6].
In the solid caseating granuloma, the central portion
enhances heterogeneously whereas the capsule presents
a ring-enhancing pattern. The rim of a caseating TB
granuloma is often strikingly hypointense on T2-weighted
images and enhances on T1-weighted gadolinium-
enhanced MRI. In the next stage, the granuloma with
central liquefaction of caseous material is seen as a
hypodense core surrounded by a dense ring of enhance-
ment on CECT and T1-weighted gadolinium-enhanced
MRI. The activity of a tuberculoma may be judged by
the degree of contrast enhancement on follow-up CT
or MRI studies.
Multiple cerebral tuberculomas as extensive as
those in our patient are rare and are thought to be
due to the immunosuppression she was subjected to
as part of the treatment for SLE. Such extensive dis-
ease is usually associated with a poor prognosis given
the enlargement of existing lesions as well as the ap-
pearance of new lesions causing increased intracranial
pressure [7]. Paradoxical worsening of symptoms fol-
lowing ATT (a previously reported phenomenon
termed paradoxical reaction) occurred in our patient
but was countered with increased doses of intraven-
ous corticosteroids [8]. In a recent review, it was
recommended that intravenous corticosteroids be con-
tinued for a longer period (four to eight weeks) to
counter the possible initial worsening of clinical sta-
tus following ATT and to consider histological exam-
ination of lesions only if a response was not apparent
by eight weeks [2]. Though not directly related to
tuberculomas, a meta-analysis by Prasad and Singh
[9] also provides evidence that steroid treatment
(prednisolone or dexamethasone) reduces mortality
(n = 1140 in seven trials, relative risk of 0.78, 95%
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when combined with ATT.
Conclusions
Our case report highlights the challenges in the diagnos-
tic workup of immunosuppressed patients presenting
with multiple ring-enhancing lesions of the brain, diffi-
culties in establishing a diagnosis of CNS TB, and the
paradoxical deterioration following ATT. Our experience
and previous evidence from case reports suggest that
physicians should not hesitate to continue with high
doses of steroids for a prolonged period (up to eight
weeks) until the patient recovers from the initial
deterioration.
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